| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 1997 | Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia (T-ALL) | Batova, A.; Diccianni, M. B.; Yu, J. C.; Nobori, T.; Link, M. P.; Pullen, J.; Yu, A. L. | Cancer Res 57, 832-836 | | | |
| 2000 | In vitro sensitivity of T-cell lymphoblastic leukemia to UCN-01 (7-hydroxy staurosporine) in dependent on p16 protein status: a pediatric oncology group study | Omura-Minamisawa, M.; Diccianni, M. B.; Batova, A.; Chang, R. C.; Bridgeman, L. J.; Yu, J.; de Wit, E.; Kung, F. H.; Pullen, J.; Yu, A. L. | Cancer Res 60, 6573-6576 | | | |
| 1997 | Shortened survival after relapse in T-cell acute lymphoblastic leukemia patients with p16/p15 deletions | Diccianni, M. B.; Batova, A.; Yu, J.; Vu, T.; Pullen, J.; Amylon, M.; Pollock, B.; Yu, A. L. | Leukemia Res 21, 549-558 | | | |
| 2001 | Thioredoxin expression in primary childhood T-cell acute lymphoblastic leukemia and its therapeutic implications | Shao, L. E.; Diccianni, M. B.; Tanaka, T.; Yu, A. L.; Bessent, E.; Pullen, J.; Yu, J. | Cancer Res 61, 7333-7338 | | | |
| 2000 | Universal inactivation of both p16 and p15 but not downstream components is an essential event in pathogenesis of T-cell acute lymphoblastic leukemia | Omura-Minamisawa, M.; Diccianni, M. B.; Batova, A.; Chang, R. C.; Bridgeman, L.; Yu, J.; Pullen, J.; Bowman, W. P.; Yu, A. L. | CLINICAL CANCER RESEARCH 6, 1219-1228 | | | |
| 1999 | Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T-cell acute lymphoblastic leukemia in vitro | Batova, A.; Diccianni, M. B.; Yu, J.; Carrera, C. J.; Bridgeman, L. J.; Kung, F. H.; Pullen, J.; Amylon, M. D.; Yu, A. L. | Cancer Research 59, 1492-1497 | | | |
